1. Locatelli F, Aljama P, Barany P, et al. for the European Best Practice Guidelines Working Group. (2004) Revised European Best Practice Guidelines for the mangement of anaemia in patients with chronic renal failure. Nephrol Dial Transplant19:Suppl 2, 1–47.
2. Aljama P, Bommer J, Canaud B, et al. for the NESP Usage Guidelines Group. (2001) Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant16:Suppl 3, 22–28.
3. Vanrenterghem Y, Barany P, Mann JF, et al. (2002) Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int62:2167–2175.
4. Hörl WH, Holzer H, Mayer GJ. Osterreichische Aranesp Studiengruppe. (2002) [German] Treatment of renal anemia with darbepoetin alfa: results of an Austrian multicenter study. Wien Klin Wochenschr114:967–971.
5. Martinez Castelao A, Reyes A, Valdes F, et al. (2003) [Spanish] Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis. Nefrologia23:114–124.